Back
1st Source Vs. Avidity Biosciences Industry Stock Comparison
Buy
53
SRCE
1st Source
Last Price:
$60.04
Seasonality Move:
3.82%
Sell
34
RNA
Avidity Biosciences
Last Price:
$32.11
Seasonality Move:
-10.33%
Buy
53
1st Source (SRCE)
is a Buy
Is 1st Source a Buy, Sell or Hold?
-
The current 1st Source [SRCE] share price is $59.98. The Score for SRCE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
SRCE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $32.13. The Score for RNA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRCE Stock Price Chart
What is 1st Source's stock price today?
-
The 1st Source share price today is $59.98Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRCE is experiencing selling pressure, which indicates risk of future bearish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $32.13The current trend is relatively stagnant and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
SRCE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 36.21 | Sell |
Chaikin Money Flow: | -47914 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (62.24 - 66.4) | Sell |
Bollinger Bands (100): | (58.92 - 65.32) | Sell |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 54.74 | Buy |
Chaikin Money Flow: | -1849074 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.71 - 33.63) | Buy |
Bollinger Bands (100): | (29.46 - 43.3) | Sell |
SRCE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.94 | Sell |
20-day SMA: | 64.09 | Sell |
50-day SMA: | 61.52 | Sell |
200-day SMA: | 59.39 | Buy |
8-day EMA: | 61.59 | Sell |
20-day EMA: | 62.79 | Sell |
50-day EMA: | 62.51 | Sell |
200-day EMA: | 59.37 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.29 | Buy |
20-day SMA: | 30.97 | Buy |
50-day SMA: | 30.96 | Buy |
200-day SMA: | 38.58 | Sell |
8-day EMA: | 30.89 | Buy |
20-day EMA: | 30.96 | Buy |
50-day EMA: | 32.21 | Sell |
200-day EMA: | 34.03 | Sell |
1st Source Earnings Growth & SRCE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.36 per share, and an increase next year of $0.15 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.99 per share, and a decrease next year of $0.57 per share.
1st Source Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |